Dysregulation of Serum miR-212-3p Serves as a Biomarker to Predict Disease Onset and Short-Term Prognosis in Acute Coronary Syndrome Patients
Serum miR-212-3p might serve as a non-invasive biomarker for ACS diagnosis and MACE prediction and as a supplementary molecular tool in clinical practice.
Authors
- Binyan Luo (ORCID: https://orcid.org/0009-0001-8946-6848)
Institutions
- Cixian People's Hospital (CN)
- First People's Hospital of Chongqing (CN)
Publication Details
- Journal
- The Anatolian Journal of Cardiology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.14744/anatoljcardiol.2025.5306
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00